Model for end-stage liver disease exceptions: proceed with caution
- PMID: 21837739
- DOI: 10.1002/lt.22402
Model for end-stage liver disease exceptions: proceed with caution
Comment on
-
The new liver allocation system: moving toward evidence-based transplantation policy.Liver Transpl. 2002 Sep;8(9):851-8. doi: 10.1053/jlts.2002.35927. Liver Transpl. 2002. PMID: 12200791
-
New national liver transplant allocation policy: is the regional review board process fair?Liver Transpl. 2004 May;10(5):666-74. doi: 10.1002/lt.20116. Liver Transpl. 2004. PMID: 15108259
-
Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.Liver Transpl. 2006 Dec;12(12 Suppl 3):S128-36. doi: 10.1002/lt.20979. Liver Transpl. 2006. PMID: 17123284 No abstract available.
-
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States.Liver Transpl. 2010 Mar;16(3):262-78. doi: 10.1002/lt.21999. Liver Transpl. 2010. PMID: 20209641
-
Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.Liver Transpl. 2011 Oct;17(10):1137-51. doi: 10.1002/lt.22363. Liver Transpl. 2011. PMID: 21695771 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
